Forward-Looking Statements
Statements in this slide presentation relating to future financial result constitute “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Some of the key risk factors that could affect actual results relative to these projections include: the ability of or sales force to increase the adoption of the AngioJet, our ability to maintain and enhance adequate production yields and margins, our ability to obtain new indications for existing products, bring enhanced products to market, open new international markets for the AngioJet, and our ability to manage and maintain patient enrollment rates in marketing and clinical trials. A discussion of the factors that could impact the Company’s future results are set forth in the cautionary statements included in Exhibit 99 to the Company’s Form 10K for the year ended July 31, 2003, filed with the Securities and Exchange Commission.